Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-08

Clinical Trial Update: Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 trial evaluating concurrent radiotherapy, temozolomide, and BMX-001 for newly diagnosed high-grade glioma has completed enrollment, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BMX-001
  • Temodar (Temozolomide)

Snippet

Sponsor: BioMimetix JV, LLC | Conditions: High Grade Glioma, Astrocytoma, Grade III | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-06-08